These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 33331943

  • 21. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B, Kasapcopur O.
    Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
    Erden A, Batu ED, Sarı A, Sönmez HE, Armagan B, Demir S, Fırat E, Bilginer Y, Bilgen SA, Karadağ Ö, Kalyoncu U, Kiraz S, Ertenli I, Özen S, Akdogan A.
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):97-102. PubMed ID: 30418112
    [Abstract] [Full Text] [Related]

  • 24. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments.
    Ozen S, Kone-Paut I, Gül A.
    Semin Arthritis Rheum; 2017 Aug; 47(1):115-120. PubMed ID: 28413100
    [Abstract] [Full Text] [Related]

  • 25. Evidence-based recommendations for the practical management of Familial Mediterranean Fever.
    Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, Amselem S, Gershoni-Baruch R, Touitou I, Ben-Chetrit E.
    Semin Arthritis Rheum; 2013 Dec; 43(3):387-91. PubMed ID: 23742958
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?
    Can Sandikci S, Omma A, Yucel C, Omma T.
    Clin Rheumatol; 2021 Feb; 40(2):669-674. PubMed ID: 32623649
    [Abstract] [Full Text] [Related]

  • 28. Non-response to colchicine in familial Mediterranean fever should be identified accurately.
    Melikoglu MA, Senel K.
    Int J Rheum Dis; 2017 Dec; 20(12):2118-2121. PubMed ID: 24702830
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.
    Tal R, Semo Oz R, Amarilyo G, Eidlitz-Marcus T, Goldberg O, Levinsky Y, Peled O, Harel L.
    Rheumatol Int; 2020 Jan; 40(1):121-128. PubMed ID: 31230112
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
    Grossman C, Farberov I, Feld O, Livneh A, Ben-Zvi I.
    Rheumatol Int; 2019 Mar; 39(3):517-523. PubMed ID: 30604205
    [Abstract] [Full Text] [Related]

  • 35. Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?
    Emmungil H, İlgen U, Turan S, Yaman S, Küçükşahin O.
    Rheumatol Int; 2020 Jan; 40(1):129-135. PubMed ID: 31463607
    [Abstract] [Full Text] [Related]

  • 36. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G, Kose R, Senturk T.
    Sao Paulo Med J; 2019 May 08; 137(1):39-44. PubMed ID: 31116269
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R, Ozturk MA, Goker B, Tufan A, Haznedaroglu S.
    J Clin Rheumatol; 2020 Jan 08; 26(1):7-13. PubMed ID: 30048391
    [Abstract] [Full Text] [Related]

  • 38. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct 08; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 39. [INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].
    Shouval R, Livneh A, Ben-Zvi I.
    Harefuah; 2015 Nov 08; 154(11):716-9, 741. PubMed ID: 26821505
    [Abstract] [Full Text] [Related]

  • 40. Current trends in colchicine treatment in familial Mediterranean fever.
    La Regina M, Ben-Chetrit E, Gasparyan AY, Livneh A, Ozdogan H, Manna R.
    Clin Exp Rheumatol; 2013 Nov 08; 31(3 Suppl 77):41-6. PubMed ID: 24064013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.